[Federal Register Volume 69, Number 94 (Friday, May 14, 2004)]
[Notices]
[Pages 26827-26828]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-10969]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Secretary's Advisory Committee on Blood Safety and Availability

AGENCY: Office of the Secretary, Office of Public Health and Science.

ACTION: Solicitation of nomination for four vacancies on the 
Secretary's Advisory Committee on Blood Safety and Availability.

-----------------------------------------------------------------------

    Authority: 42 U.S.C. 217a, Section 222 of the Public Health 
Service (PHS) Act, as amended. The Committee is governed by the 
provisions of Pub. L. 92-463, as amended (5 U.S.C. Appendix 2), 
which sets forth standards for the formation and use of advisory 
committees.

SUMMARY: The Advisory Committee on Blood Safety and Availability 
(ASBSA) provides advice to the Secretary and to the Assistant Secretary 
for Health on a range of issues that include: (1) Definition of public 
health parameters around safety and availability of the blood supply, 
(2) broad public health, ethical, and legal issues related to blood 
safety, and (3) the implications for blood

[[Page 26828]]

safety and availability of various economic factors affecting product 
cost and supply. The current charter for the ACBSA expires October 9, 
2004.

DATES: Nominations for membership on the Committee must be received no 
later than 5 p.m. e.s.t. on June 4, 2004, at the address below.
    All Nominations Should Be Mailed or Delivered To: Dr. Jerry 
Holmberg, Executive Director, Advisory Committee on Blood Safety and 
Availability, 1101 Wootten Parkway, Suite 250, Rockville, MD 20852. 
Nominations will not be accepted by e-mail or facsimile.

FOR FURTHER INFORMATION CONTACT: CAPT Lawrence McMurtry, Deputy 
Secretary, Advisory Committee on Blood Safety and Availability, 
Department of Health and Human Services, Office of Public Health and 
Science, 1101 Wootten Parkway, Suite 250, Rockville, MD 20852. 
Telephone (301) 443-2823.
    A copy of the Committee charter and list of the current membership 
can be obtained by contacting CAPT McMurtry or by accessing the ACBSA 
Web site at http://www.dhhs.gov/bloodsafety.

SUPPLEMENTARY INFORMATION: 

Nominations

    The ACBSA is requesting nominations to fill four positions that are 
scheduled to become vacant on October 1, 2004. Nominations of potential 
candidates for considerations are being sought from advocacy groups, 
provider blood organizations, academic researchers, ethicists, private 
physicians, scientists, consumer advocates, legal organizations, and 
from among communities of persons who are frequent recipients of blood 
or blood products including therapeutic protein products and their 
recombinant analogs. To qualify for consideration of appointment to the 
Committee, an individual must demonstrate experience and expertise in 
any of the several disciplines and field pertinent to blood and plasma 
therapeutics and/or clinical research.
    Individuals selected for appointment to the Committee will serve as 
voting members. Individuals selected for appointment to the Committee 
will be invited to serve a term of up to three years. Compensation for 
Committee members includes a stipend and reimbursement for per diem and 
travel expenses incurred for attendance at Committee meetings, as well 
as to conduct other business matters in the interest of the ACBSA.
    Nominations should be typewritten. The following information should 
be included in the package of material submitted for each individual 
being nominated for consideration: (1) A letter of nomination that 
clearly states the name and organizational affiliation of the nominee, 
the basis for the nomination (i.e., specific attributes which qualify 
the nominee for appointment to the Committee), and a statement that the 
nominee is willing to serve as a member of the Committee; (2) the 
nominator's name, address, and daytime telephone number, and the home 
and/or work address, telephone number, and email address of the 
individual being nominated; and (3) a current copy of the nominee's 
curriculum vitae. Federal employees should not be nominated for 
consideration of appointment to this Committee.
    The Department of Health and Human Services (DHHS) makes every 
effort to ensure that the membership of its Federal advisory committees 
is fairly balanced in terms of points of view represented and the 
committee's function. Every effort is made to ensure that a broad 
representation of geographic areas, females, ethnic and minority 
groups, and the disabled are given consideration for membership on DHHS 
Federal advisory committees. Appointment to this Committee shall be 
made without discrimination on the basis of age, race, ethnicity, 
gender, sexual orientation, disability, and cultural, religious, or 
socioeconomic status. Nominations must state that the nominee is 
willing to serve as a member of ACBSA and appears to have no conflict 
of interest that would preclude membership. If selected for appointment 
to the Committee, candidates will be asked to provide detailed 
information concerning such matters as financial holdings, 
consultancies, and research grants or contracts. Disclosure of this 
information is necessary in order to determine if the selected 
candidates are involved in activity that may conflict with the matters 
discussed by ACBSA.

    Dated: April 22, 2004.
Lawrence C. McMurtry,
Deputy Executive Secretary, Advisory Committee on Blood Safety and 
Availability, Office of the Secretary, Office of Public Health and 
Science, Department of Health and Human Services.
[FR Doc. 04-10969 Filed 5-13-04; 8:45 am]
BILLING CODE 4150-28-P